Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
While I was packing for what would be my last pre-COVID trip to the U.S., our youngest daughter sat down and asked me: "Daddy, can I ask you a question? Are you going to wear your kippah in America?" "Why do you ask?" I replied. She queried: "Well, who do they hate more in America, Blacks or Jews?" That question haunted me. Why does she have that question in her head? Then I thought: after the last four years, how could she not?
A. Gault C. Dobeson S. Haney J. Graham A. Humphreys Purpose: Neoadjuvant chemotherapy can allow for breast conserving surgery to be undertaken and for assessment of tumour response to therapy, inferring prognostic implications. We reviewed outcomes for all patients receiving neoadjuvant chemotherapy, in terms of pathological complete response (pCR) rates, to see if these were comparable with published data [1].
ORIGINAL ARTICLE S. J. Moirano E-mail address: steven.moirano@amcny.org General Medicine and Surgery, The Animal Medical Center Search for more papers by this author C. W. Dewey E-mail address: cwd27@cornell.edu Department of Clinical Sciences, Cornell University, College of Veterinary Medicine Long Island Veterinary Specialists Veterinary Specialists and Emergency Services of Rochester Search for more papers by this author S.
Prognosis of feline gastrointestinal mast cell tumours (FGIMCT), based on limited available literature, is described as guarded to poor, which may influence treatment recommendations and patient outcome. The purpose of this study is to describe the clinical findings, treatment response, and outcome of FGIMCT. Medical records of 31 cats diagnosed with and treated for FGIMCT were retrospectively reviewed.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.